# Adaptimmune Therapeutics PLC: Form 8-K, filed Aug 7, 2025

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2025-08-07
- Accepted by EDGAR: Aug 7, 2025, 16:30 ET
- Period: 2025-08-07
- Accession: 0001558370-25-010785
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000155837025010785/adap-20250807x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000155837025010785/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000155837025010785/adap-20250807x8k.htm

Filed Aug 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-010785. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.